Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05548413 · ClinicalTrials.gov registry record · NA
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
A NA study of Heart Failure and Medication Adherence, sponsored by Jia-Rong Wu.
- Recruiting
- Registry status
- NA
- Development phase
- 328
- Enrollment target
- 1
- Study location
NCT05548413: Recruiting NA study of Heart Failure and Medication Adherence, sponsored by Jia-Rong Wu.
NCT05548413 is a NA study of Heart Failure and Medication Adherence that is actively recruiting participants, run by Jia-Rong Wu. The registered enrollment target is 328 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05548413, a NA study of Heart Failure and Medication Adherence, is actively recruiting participants, sponsored by Jia-Rong Wu.
- RECRUITING
- Registry status
- NA
- Development phase
- 328 participants
- Enrollment target
- 1
- Study location
Study Summary
People with heart failure who do not take their medications as prescribed are at high risk of complications leading to hospitalization, death and poor quality of life. In the proposed intervention, nurses will use easy-to-understand language to coach patients and their care partners to help them work together and build skills to overcome their individual barriers to adherence in order to 1) improve and sustain patient medication adherence; 2) reduce hospitalization; 3) improve quality of life. If effective, this intervention will support long-term medication adherence, thus reducing hospitalizations related to heart failure and quality of life.
Primary Outcome
Percentage of prescribed doses taken (PDT%) as determined by the electronic SimpleMed+ pillbox. SimpleMed+ will record the date and time that the lid of each compartment is opened and closed. Those data will be used to calculate objective medication adherence: percent prescribed doses taken (PDT%) = (# of doses taken during monitoring period)/(# of prescribed doses during monitoring period) x 100.PDT% ranges from 0-100%.
Conditions Studied
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL FamLit
Study Locations (1)
Kentucky
- Jia-Rong Wu - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 328 participants |
| Start Date | 2023-01-04 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT05548413 shows while recruiting
NCT05548413 is an interventional study that assigns participants to a tested intervention. The registered 328 participants enrollment target is mid-sized for trials with a published cap, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.
NCT05548413 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05548413 about?
NCT05548413 is a clinical study titled "Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies". People with heart failure who do not take their medications as prescribed are at high risk of complications leading to hospitalization, death and poor quality of life. In the proposed intervention, nurses will use easy-to-understand language to coach patients and their care partners to help them wor...
What is the current status of trial NCT05548413?
This trial is currently recruiting. It is a NA study. The enrollment target is 328 participants. The study started on 2023-01-04. Estimated completion is 2027-12-31.
What conditions does trial NCT05548413 study?
This clinical trial studies the following conditions: Heart Failure, Medication Adherence.
What interventions are being tested in trial NCT05548413?
The interventions under investigation include: Attention Control (BEHAVIORAL), FamLit (BEHAVIORAL).
Who is sponsoring clinical trial NCT05548413?
This trial is sponsored by Jia-Rong Wu, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05548413 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05548413's enrollment target sits among peer trials
328 133rd of 397 higher than 265 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05156983 · 328 participants · Phase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
- NCT05380401 · 328 participants · NA
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
- NCT06393725 · 328 participants · NA
Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions
- NCT06036446 · 329 participants · NA
LATe Cerclage in High-risk Pregnancies (LATCH)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI